Ruxolitinib-alkyne is a derivative of Ruxolitinib (R702000), which is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis. Ruxolitinib-alkyne is prepared as a racemic mixture. Molecular Formula: C18H19N5 Molecular Weight: 305.38 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
305.38
* VAT and and shipping costs not included. Errors and price changes excepted
